News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
284,964 Results
Type
Article (15739)
Company Profile (108)
Press Release (269109)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (90297)
Career Advice (467)
Deals (15611)
Drug Delivery (75)
Drug Development (39135)
Employer Resources (50)
FDA (6611)
Job Trends (6505)
News (155128)
Policy (14882)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (590)
Accelerated approval (14)
Adcomms (8)
Allergies (68)
Alliances (24034)
ALS (61)
Alzheimer's disease (534)
Antibody-drug conjugate (ADC) (101)
Approvals (6813)
Artificial intelligence (221)
Autoimmune disease (41)
Automation (13)
Bankruptcy (152)
Best Places to Work (4652)
BIOSECURE Act (9)
Biosimilars (118)
Biotechnology (42)
Bladder cancer (39)
Brain cancer (32)
Breast cancer (183)
Cancer (1465)
Cardiovascular disease (160)
Career advice (419)
Career pathing (13)
CAR-T (53)
CDC (6)
Cell therapy (165)
Cervical cancer (9)
Clinical research (33375)
Collaboration (769)
Compensation (326)
Complete response letters (34)
COVID-19 (1629)
CRISPR (45)
C-suite (436)
Cystic fibrosis (65)
Data (2092)
Denatured (18)
Depression (46)
Diabetes (133)
Diagnostics (1765)
Digital health (10)
Diversity (3)
Diversity, equity & inclusion (14)
Drug discovery (121)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (81)
Earnings (34553)
Editorial (20)
Employer branding (4)
Employer resources (45)
Events (40449)
Executive appointments (536)
FDA (7801)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (4)
Funding (456)
Gene editing (75)
Generative AI (20)
Gene therapy (200)
GLP-1 (453)
Government (1738)
Grass and pollen (5)
Guidances (170)
Healthcare (4095)
HIV (19)
Huntington's disease (10)
IgA nephropathy (40)
Immunology and inflammation (69)
Immuno-oncology (14)
Indications (54)
Infectious disease (1714)
Inflammatory bowel disease (74)
Inflation Reduction Act (7)
Influenza (42)
Intellectual property (117)
Interviews (60)
IPO (6045)
IRA (33)
Job creations (2063)
Job search strategy (375)
JPM (28)
Kidney cancer (9)
Labor market (28)
Layoffs (207)
Leadership (8)
Legal (3473)
Liver cancer (22)
Longevity (9)
Lung cancer (211)
Lymphoma (132)
Machine learning (15)
Management (17)
Manufacturing (420)
MASH (75)
Medical device (1426)
Medtech (1433)
Mergers & acquisitions (9993)
Metabolic disorders (457)
Multiple sclerosis (46)
NASH (14)
Neurodegenerative disease (91)
Neuropsychiatric disorders (38)
Neuroscience (970)
Neurotech (1)
NextGen: Class of 2026 (1636)
Non-profit (652)
Now hiring (17)
Obesity (234)
Opinion (144)
Ovarian cancer (41)
Pain (111)
Pancreatic cancer (63)
Parkinson's disease (90)
Partnered (12)
Patents (230)
Patient recruitment (132)
Peanut (12)
People (29999)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8912)
Phase 2 (14162)
Phase 3 (12607)
Pipeline (2059)
Policy (138)
Postmarket research (1414)
Preclinical (3694)
Press Release (27)
Prostate cancer (92)
Psychedelics (17)
Radiopharmaceuticals (136)
Rare diseases (383)
Real estate (2681)
Recruiting (18)
Regulatory (11469)
Reports (15)
Research institute (749)
Resumes & cover letters (56)
Rett syndrome (7)
RNA editing (8)
RSV (21)
Schizophrenia (70)
Series A (81)
Series B (54)
Service/supplier (2)
Sickle cell disease (47)
Special edition (11)
Spinal muscular atrophy (82)
Sponsored (11)
Startups (1682)
State (2)
Stomach cancer (5)
Supply chain (50)
Tariffs (68)
The Weekly (45)
Vaccines (456)
Venture capital (32)
Weight loss (141)
Women's health (27)
Worklife (4)
Date
Today (1)
Last 7 days (191)
Last 30 days (757)
Last 365 days (11129)
2026 (1016)
2025 (11412)
2024 (13334)
2023 (15310)
2022 (21624)
2021 (22491)
2020 (19651)
2019 (15339)
2018 (12038)
2017 (14285)
2016 (13489)
2015 (15838)
2014 (12647)
2013 (10767)
2012 (11544)
2011 (12071)
2010 (11047)
Location
Africa (340)
Alabama (19)
Alaska (1)
Arizona (80)
Arkansas (4)
Asia (21406)
Australia (2761)
California (3533)
Canada (1521)
China (566)
Colorado (154)
Connecticut (156)
Delaware (129)
Europe (42627)
Florida (625)
Georgia (68)
Hawaii (1)
Idaho (11)
Illinois (360)
India (45)
Indiana (241)
Iowa (5)
Japan (250)
Kansas (77)
Kentucky (21)
Louisiana (6)
Maine (2)
Maryland (489)
Massachusetts (2769)
Michigan (47)
Minnesota (169)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (17)
New Hampshire (8)
New Jersey (1447)
New Mexico (7)
New York (954)
North Carolina (667)
North Dakota (2)
Northern California (1658)
Ohio (90)
Oklahoma (5)
Oregon (20)
Pennsylvania (750)
Puerto Rico (12)
Rhode Island (20)
South America (517)
South Carolina (11)
Southern California (1498)
Tennessee (54)
Texas (513)
United States (13665)
Utah (73)
Virginia (161)
Washington D.C. (42)
Washington State (267)
West Virginia (1)
Wisconsin (39)
Wyoming (1)
284,964 Results for "variant pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
November 10, 2025
·
12 min read
Press Releases
Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides
October 15, 2025
·
8 min read
Press Releases
Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans
September 24, 2025
·
7 min read
Press Releases
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
November 4, 2025
·
3 min read
Press Releases
Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
September 16, 2025
·
6 min read
Press Releases
Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
August 18, 2025
·
3 min read
Press Releases
iLeukon Receives FDA Clearance of IND Application for A Phase II Study of mRNA-based non-alpha IL-2 variant, ILKN421H, in Advanced Non-Small Cell Lung Cancer (NSCLC)
November 3, 2025
·
1 min read
Press Releases
Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
August 22, 2025
·
4 min read
Press Releases
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
August 28, 2025
·
7 min read
Press Releases
Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)
August 18, 2025
·
12 min read
1 of 28,497
Next
